Good job, Nidan!
Btw, do we know that patients haven’t begun being dosed in the PDD trial?
Think we should verify that...(not you, specifically, Nidan - I know you are quoting. I think the information should be verified...)
I don’t think we will see a PR for dosing update, just as we did not see PR for first patient enrolled in this trial nor the many sites which have become “active” status (PDD - Spain. All of this was found through DD on this board on the European Site). The only PR was for the patient enrolled first in AD.
BR,
Bio
News 
Market Data 
Discover 
